Entropy Technologies LP Takes Position in Sabra Healthcare REIT, Inc. $SBRA

Key Points

• Entropy Technologies LP acquired a new position in Sabra Healthcare REIT by purchasing 25,940 shares valued at approximately $453,000 during the 1st quarter.
• Sabra Healthcare REIT reported earnings of $0.38 EPS for the latest quarter, exceeding analyst estimates of $0.36, with a net margin of 24.87% and revenue of $189.15 million.
• The company announced a quarterly dividend of $0.30 per share, which represents an annualized dividend yield of 6.5%.

Entropy Technologies LP purchased a new stake in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm purchased 25,940 shares of the real estate investment trust's stock, valued at approximately $453,000.

Several other large investors have also recently modified their holdings of SBRA. Wells Fargo & Company MN raised its stake in shares of Sabra Healthcare REIT by 13.4% during the fourth quarter. Wells Fargo & Company MN now owns 349,804 shares of the real estate investment trust's stock valued at $6,059,000 after acquiring an additional 41,227 shares during the last quarter. Envestnet Asset Management Inc. increased its position in shares of Sabra Healthcare REIT by 6.9% during the fourth quarter. Envestnet Asset Management Inc. now owns 559,789 shares of the real estate investment trust's stock worth $9,696,000 after buying an additional 36,104 shares during the period. Federated Hermes Inc. increased its position in shares of Sabra Healthcare REIT by 39.7% during the fourth quarter. Federated Hermes Inc. now owns 22,123 shares of the real estate investment trust's stock worth $383,000 after buying an additional 6,282 shares during the period. Invesco Ltd. increased its position in shares of Sabra Healthcare REIT by 9.9% during the fourth quarter. Invesco Ltd. now owns 2,556,218 shares of the real estate investment trust's stock worth $44,274,000 after buying an additional 229,708 shares during the period. Finally, Raymond James Financial Inc. acquired a new stake in shares of Sabra Healthcare REIT during the fourth quarter worth $887,000. Institutional investors own 99.40% of the company's stock.

Sabra Healthcare REIT Stock Up 1.0%

SBRA stock traded up $0.19 during mid-day trading on Monday, reaching $18.65. 673,814 shares of the company traded hands, compared to its average volume of 2,450,447. Sabra Healthcare REIT, Inc. has a fifty-two week low of $15.60 and a fifty-two week high of $20.03. The stock has a market cap of $4.47 billion, a price-to-earnings ratio of 24.57, a P/E/G ratio of 1.53 and a beta of 0.86. The firm's 50 day moving average price is $18.33 and its 200 day moving average price is $17.62. The company has a quick ratio of 4.80, a current ratio of 4.80 and a debt-to-equity ratio of 0.91.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last released its quarterly earnings results on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.02. Sabra Healthcare REIT had a net margin of 24.87% and a return on equity of 6.69%. The business had revenue of $189.15 million for the quarter, compared to analysts' expectations of $185.64 million. During the same period in the previous year, the company earned $0.36 earnings per share. The firm's revenue for the quarter was up 7.4% compared to the same quarter last year. As a group, equities research analysts predict that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, August 29th. Investors of record on Friday, August 15th will be issued a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.4%. The ex-dividend date of this dividend is Friday, August 15th. Sabra Healthcare REIT's payout ratio is 157.89%.

Analyst Upgrades and Downgrades

SBRA has been the subject of several research analyst reports. Scotiabank lifted their price objective on Sabra Healthcare REIT from $19.00 to $20.00 and gave the stock a "sector perform" rating in a research report on Monday, June 23rd. JMP Securities lifted their price objective on Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a "market outperform" rating in a research report on Wednesday, August 6th. Three investment analysts have rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, Sabra Healthcare REIT presently has an average rating of "Moderate Buy" and a consensus target price of $20.00.

Insider Activity at Sabra Healthcare REIT

In related news, Director Michael J. Foster sold 11,000 shares of Sabra Healthcare REIT stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $18.22, for a total value of $200,420.00. Following the sale, the director owned 64,725 shares of the company's stock, valued at approximately $1,179,289.50. The trade was a 14.53% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 1.10% of the company's stock.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.